| Literature DB >> 30566567 |
Timothy M Uyeki1, Henry H Bernstein2, John S Bradley3,4, Janet A Englund5, Thomas M File6, Alicia M Fry1, Stefan Gravenstein7, Frederick G Hayden8, Scott A Harper9, Jon Mark Hirshon10, Michael G Ison11, B Lynn Johnston12, Shandra L Knight13, Allison McGeer14, Laura E Riley15, Cameron R Wolfe16, Paul E Alexander17,18, Andrew T Pavia19.
Abstract
These clinical practice guidelines are an update of the guidelines published by the Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. This document addresses new information regarding diagnostic testing, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal influenza. It is intended for use by primary care clinicians, obstetricians, emergency medicine providers, hospitalists, laboratorians, and infectious disease specialists, as well as other clinicians managing patients with suspected or laboratory-confirmed influenza. The guidelines consider the care of children and adults, including special populations such as pregnant and postpartum women and immunocompromised patients. Published by Oxford University Press for the Infectious Diseases Society of America 2018.Entities:
Keywords: chemoprophylaxis; diagnostic testing; institutional outbreaks; seasonal influenza; treatment
Year: 2019 PMID: 30566567 PMCID: PMC6653685 DOI: 10.1093/cid/ciy866
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079